280 related articles for article (PubMed ID: 16822552)
1. T-cell trafficking competence is required for CNS invasion.
Lees JR; Archambault AS; Russell JH
J Neuroimmunol; 2006 Aug; 177(1-2):1-10. PubMed ID: 16822552
[TBL] [Abstract][Full Text] [Related]
2. Encephalitogenic T-cells increase numbers of CNS T-cells regardless of antigen specificity by both increasing T-cell entry and preventing egress.
Lees JR; Sim J; Russell JH
J Neuroimmunol; 2010 Mar; 220(1-2):10-6. PubMed ID: 20167381
[TBL] [Abstract][Full Text] [Related]
3. Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma.
Archambault AS; Sim J; Gimenez MA; Russell JH
Eur J Immunol; 2005 Apr; 35(4):1076-85. PubMed ID: 15761850
[TBL] [Abstract][Full Text] [Related]
4. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
5. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction.
Prasad R; Giri S; Nath N; Singh I; Singh AK
J Neurosci Res; 2006 Aug; 84(3):614-25. PubMed ID: 16770773
[TBL] [Abstract][Full Text] [Related]
6. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
7. CNS-irrelevant T-cells enter the brain, cause blood-brain barrier disruption but no glial pathology.
Smorodchenko A; Wuerfel J; Pohl EE; Vogt J; Tysiak E; Glumm R; Hendrix S; Nitsch R; Zipp F; Infante-Duarte C
Eur J Neurosci; 2007 Sep; 26(6):1387-98. PubMed ID: 17880383
[TBL] [Abstract][Full Text] [Related]
8. Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.
Wang C; Wang C; Dong H; Wu XM; Wang C; Xia F; Li G; Jia X; He S; Jiang X; Li H; Xu H
Mol Immunol; 2013 Jan; 53(1-2):43-51. PubMed ID: 22796503
[TBL] [Abstract][Full Text] [Related]
9. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
[TBL] [Abstract][Full Text] [Related]
10. CXCR3 blockade inhibits T-cell migration into the CNS during EAE and prevents development of adoptively transferred, but not actively induced, disease.
Sporici R; Issekutz TB
Eur J Immunol; 2010 Oct; 40(10):2751-61. PubMed ID: 21038468
[TBL] [Abstract][Full Text] [Related]
11. Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment?
Sayed BA; Christy AL; Walker ME; Brown MA
J Immunol; 2010 Jun; 184(12):6891-900. PubMed ID: 20488789
[TBL] [Abstract][Full Text] [Related]
12. Differential immune cell dynamics in the CNS cause CD4+ T cell compartmentalization.
Siffrin V; Brandt AU; Radbruch H; Herz J; Boldakowa N; Leuenberger T; Werr J; Hahner A; Schulze-Topphoff U; Nitsch R; Zipp F
Brain; 2009 May; 132(Pt 5):1247-58. PubMed ID: 19179377
[TBL] [Abstract][Full Text] [Related]
13. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
[TBL] [Abstract][Full Text] [Related]
14. GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions.
Prasad R; Giri S; Nath N; Singh I; Singh AK
Glia; 2007 Jan; 55(1):65-77. PubMed ID: 17019693
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
[TBL] [Abstract][Full Text] [Related]
16. Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study.
Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Bendszus M; Stoll G
Exp Neurol; 2009 Nov; 220(1):207-11. PubMed ID: 19733560
[TBL] [Abstract][Full Text] [Related]
17. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis.
Li O; Liu JQ; Zhang H; Zheng P; Liu Y; Bai XF
Scand J Immunol; 2006 Aug; 64(2):117-24. PubMed ID: 16867156
[TBL] [Abstract][Full Text] [Related]
18. Cell surface levels of endothelial ICAM-1 influence the transcellular or paracellular T-cell diapedesis across the blood-brain barrier.
Abadier M; Haghayegh Jahromi N; Cardoso Alves L; Boscacci R; Vestweber D; Barnum S; Deutsch U; Engelhardt B; Lyck R
Eur J Immunol; 2015 Apr; 45(4):1043-58. PubMed ID: 25545837
[TBL] [Abstract][Full Text] [Related]
19. Encephalitogenic lymphoblast recruitment to resting CNS microvasculature: a natural immunosurveillance mechanism?
Alon R
J Clin Invest; 2001 Aug; 108(4):517-9. PubMed ID: 11518723
[No Abstract] [Full Text] [Related]
20. Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis.
Fife BT; Paniagua MC; Lukacs NW; Kunkel SL; Karpus WJ
J Neurosci Res; 2001 Nov; 66(4):705-14. PubMed ID: 11746391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
